Clinical trial · Interventional
The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy
NCT00237965CI-TRIAL-00000187completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mole Mapping Diagram | Behavioral | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female subjects above age 18 of any ethnicity will be enrolled in this study. Exclusion Criteria: * Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects. * Since the study instructions are in English, Non-English speakers will be excluded. * Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded. * In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.